{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:02:46Z","timestamp":1785308566959,"version":"3.55.0"},"reference-count":18,"publisher":"Baskent University","issue":"Supp 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.6002\/ect.mesot2025.l33","type":"journal-issue","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:14:38Z","timestamp":1785233678000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Tinckam K. Histocompatibility methods. Transplant Rev (Orlando). 2009;23(2):80-93. doi:10.1016\/j.trre.2009.01.001","DOI":"10.1016\/j.trre.2009.01.001"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Tinckam KJ, Chandraker A. Mechanisms and role of HLA and non-HLA alloantibodies. Clin J Am Soc Nephrol. 2006;1(3):404-414. doi:10.2215\/CJN.00270106","DOI":"10.2215\/CJN.00270106"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Bray RA, Nickerson PW, Kerman RH, Gebel HM. Evolution of HLA antibody detection: technology emulating biology. Immunol Res. 2004;29(1-3):41-54. doi:10.1385\/IR:29:1-3:041","DOI":"10.1385\/IR:29:1-3:041"},{"key":"ref3","unstructured":"4. SAS Institute, Inc. Principal Component Analysis. https:\/\/support.sas.com\/publishing\/pubcat\/chaps\/55129.pdf"},{"key":"ref4","unstructured":"5. Shlens J. A tutorial on principal component analysis. ArXiv. 2014;abs\/1404.1100"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Marsh SGE, Parham P, Barber LD. 4 - HLA class I antigens and alleles: workshops and nomenclature. In: Marsh SGE, Parham P, Barber LD, eds. The HLA FactsBook. Academic Press; 2000:14-25.","DOI":"10.1016\/B978-012545025-6\/50132-5"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Cano P, Klitz W, Mack SJ, et al. Common and well-documented HLA alleles: report of the Ad-Hoc committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol. 2007;68(5):392-417. doi:10.1016\/j.humimm.2007.01.014","DOI":"10.1016\/j.humimm.2007.01.014"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Marsh SG, Albert ED, Bodmer WF, et al. An update to HLA nomenclature, 2010. Bone Marrow Transplant. 2010;45(5):846-848. doi:10.1038\/bmt.2010.79","DOI":"10.1038\/bmt.2010.79"},{"key":"ref8","unstructured":"9. Terasaki PI. Histocompatibility Testing 1980: Report of the Eighth International Histocompatibility Workshop. UCLA Tissue Typing Laboratory; 1980."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Gebel HM, Moussa O, Eckels DD, Bray RA. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums. Hum Immunol. 2009;70(8):610-617. doi:10.1016\/j.humimm.2009.04.012","DOI":"10.1016\/j.humimm.2009.04.012"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Genser B, Cooper PJ, Yazdanbakhsh M, Barreto ML, Rodrigues LC. A guide to modern statistical analysis of immunological data. BMC Immunol. 2007;8:27. doi:10.1186\/1471-2172-8-27","DOI":"10.1186\/1471-2172-8-27"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. De Groot AS, Sbai H, Aubin CS, McMurry J, Martin W. Immuno-informatics: mining genomes for vaccine components. Immunol Cell Biol. 2002;80(3):255-269. doi:10.1046\/j.1440-1711.2002.01092.x","DOI":"10.1046\/j.1440-1711.2002.01092.x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. De Groot AS, Moise L. New tools, new approaches and new ideas for vaccine development. Expert Rev Vaccines. 2007;6(2):125-127. doi:10.1586\/14760584.6.2.125","DOI":"10.1586\/14760584.6.2.125"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Gama ME, Costa JM, Pereira JC, Gomes CM, Corbett CE. Serum cytokine profile in the subclinical form of visceral leishmaniasis. Braz J Med Biol Res. 2004;37(1):129-136. doi:10.1590\/s0100-879x2004000100018","DOI":"10.1590\/S0100-879X2004000100018"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Mutapi F, Mduluza T, Roddam AW. Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups. Immunol Lett. 2005;96(2):231-240. doi:10.1016\/j.imlet.2004.08.017","DOI":"10.1016\/j.imlet.2004.08.017"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Gilchrist M, Thorsson V, Li B, et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature. 2006;441(7090):173-178. doi:10.1038\/nature04768","DOI":"10.1038\/nature04768"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Raychaudhuri S, Stuart JM, Altman RB. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput. 2000:455-466. doi:10.1142\/9789814447331_0043","DOI":"10.1142\/9789814447331_0043"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904-909. doi:10.1038\/ng1847","DOI":"10.1038\/ng1847"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:19:26Z","timestamp":1785305966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2026\/24\/6\/2\/57\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"journal-issue":{"issue":"Supp 2","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2025.l33","relation":{},"ISSN":["1304-0855"],"issn-type":[{"value":"1304-0855","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}